Skip 
Navigation Link

1215 South Walnut Ave.
Demopolis, AL 36732 map map 

Access to Care: 334.289.2410

Health Policy & Advocacy
Resources
Basic InformationMore InformationLatest News
Blood Donations Needed: Red CrossKeep Unused Meds Out of the Hands of AddictsFew U.S. Universities Are Smoke-FreeNeed Emergency Air Lift to Hospital? It Could Cost You $40,000California Took on Anti-Vaxxers, and WonAnti-Vaccine Movement a 'Man-Made' Health Crisis, Scientists WarnAHA News: Even the Threat of Homelessness May Bring Higher Stroke RiskFDA Warns Two Kratom Marketers About False ClaimsExperts Want Doctors to Add Vaping to Youth Prevention PitchMany Health Care Workers With Flu, Colds Still Go to Work: StudyGlobal Efforts to Cut Smoking Show Mixed ResultsOne Simple Food Substitution Might Help Save the PlanetAHA News: 3 Simple Steps Could Save 94 Million Lives WorldwideRace Affects Life Expectancy in Major U.S. CitiesDrugstores Often Don't Have Opioid Antidote in Stock, Philly Study ShowsAntibiotics Pollute Rivers Worldwide: StudyAHA News: For LGBTQ Patients, Discrimination Can Become Barrier to Medical CareImmigrants Make Up 1 in 4 U.S. Health Care WorkersFDA Takes Hard Look at CBDPatients Who Read Doctors' Notes More Likely to Take Their MedsU.S. Measles Cases for 2019 Already Exceed All Annual Totals Since 1992: CDCBreathe Easier, New York City: Clean-Air Taxi Rules Are WorkingDoctor Burnout Costly for Patients, Health Care SystemBlood Banks Could Help Screen for Hereditary High CholesterolRed Cross Needs Type O Blood to Ease ShortageLess Pain, More Car Crashes: Legalized Marijuana a Mixed BagPolitical Controversies Could Fuel Bullying of LGBT Youth: StudyCBD -- It's Everywhere, But Does It Work?Brief EMS Training Saves Lives After Brain InjuryU.S. Improves Emergency Readiness, but Gaps PersistSlowing Climate Change Could Cut Health Costs, Save MoneyDispensing Opioid Antidote Without a Prescription Might Save LivesNot Just Opioids: Deaths Tied to Cocaine, Meth Are Soaring, TooMost Americans Hit Hard by Medical BillsYour Virtual Doctor Will 'See' You NowHigh Measles Rates Mean Kids, Adults Need Proper Vaccination: CDCMany Drivers Testing Positive for Marijuana, Even With Kids in CarMedicaid Could Save $2.6 Billion a Year With Dip in SmokingFDA Halts All Sales of Pelvic Mesh Products Tied to Injuries in WomenAnother Cost of the Opioid Epidemic: Billions of Dollars in Lost TaxesHealth Tip: Using an AEDNurse Practitioners Often Restricted From Prescribing Opioid TreatmentsForested Counties Have Lower Medicare Costs, Study FindsSimple CPR Doubles Survival OddsUninsured Get Short Shrift on Hospital StaysSpecial Bag Helps Patients Get Rid of Unused OpioidsHealth Tip: Responsibilities of Non-VaccinationDo Doctors Hounded by Malpractice Claims Just Shift Their Practice Elsewhere?Bans on Texting While Behind the Wheel Making Roads SaferColorado Sees Spike in ER Visits After Pot Made Legal
Questions and AnswersVideosLinksBook Reviews
Related Topics

Health Insurance
Healthcare

FDA Warns Two Kratom Marketers About False Claims

HealthDay News
by -- Robert Preidt
Updated: Jun 25th 2019

new article illustration

TUESDAY, June 25, 2019 (HealthDay News) -- The U.S. Food and Drug Administration on Tuesday took two kratom marketers to task over false claims that their products can treat or cure opioid addiction.

The latest salvo is part of the agency's continuing efforts to alert consumers about the potential dangers of the herbal drug.

The warning letters were sent to Cali Botanicals of Folsom, Calif., and Kratom NC of Wilmington, N.C., for illegally selling unapproved, misbranded kratom-containing drug products with unproven claims about their ability to treat or cure opioid addiction and withdrawal symptoms.

The companies also make unproven claims that the products treat pain and other medical conditions such as depression, anxiety and cancer.

The companies were given 15 working days to outline what actions they'll take to address the FDA's concerns. Failure to act may result in product seizures or injunctions.

"We have issued numerous warnings about the serious risks associated with the use of kratom, including warnings about the contamination of kratom products with high rates of salmonella that put people using kratom products at risk, and resulted in numerous illnesses and recalls," Acting FDA Commissioner Dr. Ned Sharpless said in an agency news release.

"As part of our efforts to assess kratom for contamination in the products tested, we also found high levels of heavy metals in kratom products. Despite our warnings, companies continue to sell this dangerous product and make deceptive medical claims that are not backed by science or any reliable scientific evidence," Sharpless added.

"As we work to combat the opioid crisis, we cannot allow unscrupulous vendors to take advantage of consumers by selling products with unsubstantiated claims that they can treat opioid addiction or alleviate other medical conditions," he said.

Kratom (Mitragyna speciosa), a plant that grows naturally in Thailand, Malaysia, Indonesia and Papua New Guinea, is not legally marketed in the United States as a drug or dietary supplement. There are no FDA-approved uses for kratom, and the agency said it has received reports about dangers posed by kratom.

Data suggest that certain substances in kratom have opioid properties that put users at risk of addiction, abuse and dependence, according to the FDA.

A U.S. Centers for Disease Control and Prevention study published in April found that over an 18-month period (July 2016 through December 2017), kratom was a contributing factor in 91 drug overdose deaths.

In seven of those cases, kratom was the only drug detected in postmortem testing, according to the study that examined data from 27 states.

Along with those 91 deaths in which kratom was at least a contributing factor, 61 other people who suffered fatal drug overdoses were found to have kratom in their bloodstreams, although other drugs may have caused the deaths, the CDC researchers said at the time.

The FDA warns consumers not to use any products labeled as containing the botanical substance kratom or its psychoactive compounds, mitragynine and 7-hydroxymitragynine.

The U.S. Drug Enforcement Agency has also listed kratom as a "drug of concern."

More information

The U.S. Food and Drug Administration has more on kratom.